SG

Sergei Gryaznov

GE Geron: 36 patents #4 of 147Top 3%
LT Lynx Therapeutics: 19 patents #2 of 24Top 9%
EX Exicure: 8 patents #1 of 14Top 8%
Northwestern University: 8 patents #152 of 3,846Top 4%
Johnson & Johnson: 7 patents #1,413 of 7,810Top 20%
University Of Texas System: 4 patents #745 of 6,559Top 15%
University of California: 1 patents #8,022 of 18,278Top 45%
UR University Of Rochester: 1 patents #496 of 1,162Top 45%
HF Healthpartners Research Foundation: 1 patents #9 of 25Top 40%
📍 San Mateo, CA: #26 of 3,727 inventorsTop 1%
🗺 California: #3,181 of 386,348 inventorsTop 1%
Overall (All Time): #21,030 of 4,157,543Top 1%
83
Patents All Time

Issued Patents All Time

Showing 26–50 of 83 patents

Patent #TitleCo-InventorsDate
10182988 Liposomal particles, methods of making same and uses thereof Chad A. Mirkin, SonBinh T. Nguyen, Resham Singh Banga, Natalia Chernyak, Aleksandar Filip Radovic-Moreno +1 more 2019-01-22
10035815 Synthesis of protected 3′-amino nucleoside monomers Krisztina Pongracz, Daria Zielinska 2018-07-31
10035814 Guanine analogs as telomerase substrates and telomere length affectors Ronald A. Pruzan, Krisztina Pongracz 2018-07-31
9822360 RNA amidates and thioamidates for RNAi Krisztina Pongracz 2017-11-21
9771581 C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders Daria Zielinska, Ronald A. Pruzan, Jeffrey Lindquist 2017-09-26
9765109 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use Ronald G. Schultz 2017-09-19
9732114 Compounds having anti-adhesive effects on cancer cells Jerry Shay, Woodring Wright 2017-08-15
9657296 Modified oligonucleotides for telomerase inhibition Krisztina Pongracz 2017-05-23
9593137 Guanine analogs as telomerase substrates and telomere length affectors Ronald A. Pruzan, Krisztina Pongracz 2017-03-14
9572891 Oligonucleotide conjugates Krisztina Pongracz, Richard L. Tolman, Gregg B. Morin 2017-02-21
9404112 Modified oligonucleotides for telomerase inhibition Krisztina Pongracz 2016-08-02
9388416 Modified oligonucleotides for telomerase inhibition Krisztina Pongracz 2016-07-12
9388415 Modified oligonucleotides for telomerase inhibition Krisztina Pongracz 2016-07-12
9365606 Synthesis of protected 3′-amino nucleoside monomers Krisztina Pongracz, Daria Zielinska 2016-06-14
9228189 C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders Daria Zielinska, Ronald A. Pruzan, Jeffrey Lindquist 2016-01-05
9133233 RNA amidates and thioamidates for RNAi Krisztina Pongracz 2015-09-15
9072790 Oligonucleotide conjugates Krisztina Pongracz, Richard L. Tolman, Gregg B. Morin 2015-07-07
8906615 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use Ronald G. Schultz 2014-12-09
8785409 Compounds having anti-adhesive effects on cancer cells Jerry Shay, Woodring Wright 2014-07-22
8748593 Synthesis of protected 3′-amino nucleoside monomers Krisztina Pongracz, Daria Zielinska 2014-06-10
8440635 Oligonucleotide conjugates Krisztina Pongracz, Richard L. Tolman, Gregg B. Morin 2013-05-14
8377644 2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use Ronald G. Schultz 2013-02-19
8153604 CNS-tumor treatment method and composition Dennis F. Deen, William H. Frey, II 2012-04-10
7989603 2′-arabino-fluorooligonucleotide N3′-P5′ phosphoramidates: their synthesis and use Ronald G. Schultz 2011-08-02
7563618 Oligonucleotide conjugates Krisztina Pongracz, Richard L. Tolman, Gregg B. Morin 2009-07-21